In March 2020, the World Health Organization declared a pandemic due to the emergence of SARS-CoV2, which causes COVID-19, a potentially lethal respiratory infection. To date, apart from the novel Molnupiravir and Ritonavir, there are no orally or nasally administered antiviral agents to prevent or treat SARS-CoV2 infections.
With funding from IDRC, a research team from the Prospective Urban Rural Epidemiology (PURE) study, a large international population research effort coordinated by McMaster University’s Population Health Research Institute (PHRI), is studying why some people get COVID-19 and others do not.
“Rethinking Partnership Paradigms in Global Health” is the theme of the Canadian Conference on Global Health 2021 (CCGH 2021) taking place from November 24 to 26. It will be a hybrid event with most attendees attending virtually and small in-person sessions at the Delta Hotel in Ottawa.
This project will study the effects of COVID-19 on the health of refugees and Indigenous populations in parts of rural Guatemala that are experiencing recent waves of refugees migrating into Indigenous communities.
Aedes mosquito-transmitted illnesses, namely dengue, chikungunya, and Zika, have become a major burden of disease in Latin America and the Caribbean, where vector control programs have not been able to reduce the risk of disease transmission.
In Latin America and the Caribbean (LAC), a steady increase in the consumption of ultra-processed food with high levels of fat, sugar, and salt has contributed to an adult overweight rate of over 50% and an obesity rate of 23%.
Over the last two decades, the United Nations Framework Convention on Climate Change (UNFCCC) has become one of the major international bodies searching for scientific and political agreements between developing and developed countries.